Literature DB >> 26308844

Cerebral radiation necrosis: diagnostic challenge and clinical management.

S C Eisele, J Dietrich1.   

Abstract

Cerebral radiation is an indispensable cornerstone in the treatment of many primary and metastatic brain tumors. However, besides its desired therapeutic effect on tumor cells, a significant proportion of patients will experience neurotoxic side effects as the consequence of radiotherapy. Radiation necrosis can result in progressive neurological symptoms and radiographic changes. To differentiate radiation necrosis from progressive tumor based on imaging can pose a diagnostic challenge because the MRI characteristics may be similar in both situations. Therefore, surgical biopsy and pathological confirmation is sometimes necessary to guide further management. Effective treatment options for cerebral radiation necrosis exist and should be offered to symptomatic patients. A better understanding of the cellular and molecular processes underlying the development of radiation necrosis is necessary to prevent and minimize radiation-associated morbidity and to improve treatment strategies.

Entities:  

Mesh:

Year:  2015        PMID: 26308844

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  4 in total

1.  RIP1 and RIP3 complex regulates radiation-induced programmed necrosis in glioblastoma.

Authors:  Arabinda Das; Daniel G McDonald; Yaenette N Dixon-Mah; Dustin J Jacqmin; Vikram N Samant; William A Vandergrift; Scott M Lindhorst; David Cachia; Abhay K Varma; Kenneth N Vanek; Naren L Banik; Joseph M Jenrette; Jeffery J Raizer; Pierre Giglio; Sunil J Patel
Journal:  Tumour Biol       Date:  2015-12-18

Review 2.  Assessment of Brain Tumor Response: RANO and Its Offspring.

Authors:  Sylvia C Eisele; Patrick Y Wen; Eudocia Q Lee
Journal:  Curr Treat Options Oncol       Date:  2016-07

3.  Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation.

Authors:  Hongqing Zhuang; Xiangkun Yuan; Joe Y Chang; Yongchun Song; Junjie Wang; Zhiyong Yuan; Xiaoguang Wang; Ping Wang
Journal:  Oncotarget       Date:  2016-07-26

4.  Defining Treatment-Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment-Induced Necrosis.

Authors:  Sebastian F Winter; Eugene J Vaios; Alona Muzikansky; Maria Martinez-Lage; Marc R Bussière; Helen A Shih; Jay Loeffler; Philipp Karschnia; Franziska Loebel; Peter Vajkoczy; Jorg Dietrich
Journal:  Oncologist       Date:  2020-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.